Voice your opinion on congressional bill S2103-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Affordable Insulin Approvals Now Act

This bill requires the continued review and approval, as appropriate, of certain pending applications for generic insulin beyond the March 23, 2020, cutoff date previously established by the Food and Drug Administration. Beginning March 23, 2020, these approved generic insulin drugs also are deemed licensed biological products.

Senate Actions

IntroReferral
Jul. 11 2019	Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)

Library of Congress Actions

IntroReferral
Jul. 11 2019	Introduced in Senate

Senate bill S2103-116

Affordable Insulin Approvals Now Act

Promote the cause!

Or use this QR code